Satellos Bioscience Inc.

MSLE | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.75

+$0.05 (+0.75%)

Nov 2, 2026, 11:10 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Cash & Equivalents	9.8M	40.18M	22.07M	1.9M	3.82M	709.08K
Short-Term Investments	17.91M	8.5M	17.52M	n/a	n/a	10.07K
Long-Term Investments	n/a	n/a	41K	41.58K	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	370K	436.18K	n/a	257.4K	414.1K	410.01K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	587K	2.97K	0	n/a
Total Current Assets	31.88M	50.87M	40.32M	2.21M	4.27M	1.13M
Property-Plant & Equipment	5K	3.48K	19K	8.91K	6.43K	1.69K
Goodwill & Intangibles	n/a	n/a	3.92M	3.88M	5.6M	n/a
Total Long-Term Assets	5K	3.48K	3.98M	3.93M	5.6M	1.69K
Total Assets	31.89M	50.88M	44.3M	6.14M	9.87M	1.13M
Account Payables	1.77M	2.07M	1.04M	1.45M	885.34K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	0	220.46K
Total Current Liabilities	4.11M	3.59M	3.62M	2.8M	1.65M	220.46K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	1.1M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	1.1M
Total Liabilities	4.11M	3.59M	3.62M	2.8M	1.65M	1.32M
Total Debt	n/a	n/a	n/a	n/a	n/a	1.1M
Book Value	27.78M	47.28M	40.67M	3.34M	8.22M	-184.25K
Book Value Per Share	22.84	4.94	5.65	1.12	4.10	-0.12
Common Stock	85.83M	73.67M	61.92M	29.91M	22.21M	4.36M
Retained Earnings	-81.97M	-52.68M	-47.5M	-31.3M	-15.91M	-4.8M
Comprehensive Income	-1.72M	-151.2K	17.76M	-6.93K	-1.13K	1.44M
Shareholders Equity	27.78M	47.28M	40.67M	3.34M	8.22M	-184.25K
Total Investments	17.91M	8.5M	17.56M	41.58K	n/a	10.07K